If you are a health practitioner, researcher, clinician, official, advocate, or just someone who wants to learn more about how LDN treatment has helped over 50,000 people with Multiple Sclerosis, Rheumatoid Arthritis, Crohn’s Disease, other autoimmune disorders, Cancer and HIV / Aids, you will not want to miss this informative event. As the public awareness and acceptance of LDN treatment grows, The 5th Annual Low Dose Naltrexone Conference promises to offer the latest insights of how use of the drug is challenging many medical assumptions of today.
Project LDN: Funding Clinical Trials is the conference theme this year and represents a call to action for all those interested in seeing LDN treatment advance as a mainstream protocol. The current agenda now includes presentations by Dr. Burt Berkson, Pharmacist Skip Lenz, and author Mary Boyle Bradley. Plenty of time will be allotted to answer attendee questions, meet with people who have in-depth experience with LDN treatment, as well as the open discussion of ideas on how to best fund future research and study of LDN.
There is no charge for attending the conference. However, if you would like to make a donation you can give in two ways:
Upon conclusion of the conference, this website will next become a point-of-contact for all LDN clinical trial fundraising efforts - a place to view financial progress, communicate important information and post helpful resources.
BECAUSE NIH IS A SECURE FACILITY YOU MUST REGISTER BY OCTOBER 7th TO ATTEND.
